SELLAS Life Sciences Group, Inc. ( SLS) - Stock Earnings
SLS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -6.8 million USD | — USD |
| 2025Q4 | -7.7 million USD | — USD |
| 2026Q1 | -8.4 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
SLS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -37.3 million USD | — USD |
| 2024 | -30.9 million USD | — USD |
| 2025 | -26.9 million USD | — USD |
| 2026 Est. | — | — |
SLS
Price: $7.73
52 week price:
Earnings Per Share: -0.23 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 183300
Ebitda: -4.4 millionMarket Capitalization: 1.2 billion